ABEO
ABEONA THERAPEUTICS INC.
NASDAQ · Healthcare · Biotechnology · US
$4.41
−0.45%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 11.32x
- P/S forward
- 2.71x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.97x
- Price / sales
- 9.88x
- Price / cash flow
- -3.30x
Enterprise value
- Enterprise value
- $125.2M
- EV / sales
- 4.91x
- EV / EBITDA
- -1.76x
- EV / EBIT
- -1.50x
- Market cap
- $252.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026